Back to the Top
The following message was posted to: PharmPK
Dear All
In BE guidance of Fexofenadine Hydrochloride Orally Disintegrating Tablets
it is mentioned that only fasting study is required for
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm086183.pdf
But for Fexofenadine Hydrochloride suspension and IR formulation fating and
fed both studies are required.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm082258.pdf
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm086185.pdf
Even in SBoA, it is mentioned that food decreases the Cmax by 60% and AUC
by 40% for ODT, then why only fasting study is required for ODT and Fast
and Fed both for IR?
In BE guidance it is written that The whole tablet should be placed on the
tongue and allowed to disintegrate for 30 seconds. After 30 seconds, all
subjects should consume 240 mL of water.It means it will be a sort of IR
formulation only and In PIL its written ALLEGRA ODT should be taken on an
empty stomach
What could be the rational behind doing only fasting biostudy for
Fexofenadine Hydrochloride Orally Disintegrating Tablets?
Warm Regards
--
Bhupesh
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Fexofenadine ODT: Study requirement" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)